Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)
Clinical trial NCT04646356 · COMPLETED
Trial details
- NCT number
- NCT04646356
- Sponsor
- Unity Health Toronto
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-20
- Primary completion
- 2024-01-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.